Corient Private Wealth
GILD icon

Corient Private Wealth’s Gilead Sciences GILD Stock Holding History

Corient Private Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68M Sell
538,310
-81,079
-13% -$10.7M 0.09% 193
2026
Q1 		$86.1M Buy
619,389
+17,540
+3% +$2.46M 0.12% 157
2025
Q4 		$73.9M Buy
601,849
+30,144
+5% +$3.66M 0.1% 190
2025
Q3 		$63.5M Sell
571,705
-24,396
-4% -$2.77M 0.1% 197
2025
Q2 		$66.1M Sell
596,101
-951
-0.2% -$101K 0.09% 197
2025
Q1 		$66.9M Sell
597,052
-35,751
-6% -$3.69M 0.11% 183
2024
Q4 		$58.5M Buy
632,803
+1,163
+0.2% +$105K 0.1% 201
2024
Q3 		$53M Sell
631,640
-27,997
-4% -$2.14M 0.08% 232
2024
Q2 		$45.3M Sell
659,637
-35,385
-5% -$2.36M 0.08% 236
2024
Q1 		$50.9M Sell
695,022
-31,957
-4% -$2.46M 0.09% 219
2023
Q4 		$58.9M Sell
726,979
-32,851
-4% -$2.56M 0.11% 193
2023
Q3 		$56.9M Sell
759,830
-17,414
-2% -$1.34M 0.13% 169
2023
Q2 		$59.9M Buy
777,244
+257,810
+50% +$20.6M 0.14% 156
2023
Q1 		$43.1M Buy
519,434
+166,913
+47% +$13.8M 0.12% 174
2022
Q4 		$30.3M Buy
+352,521
New +$27.9M 0.11% 199

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Corient Private Wealth's GILD Position: Q2 2026 in Review

Corient Private Wealth reduced its Gilead Sciences (GILD) stake by 13% in Q2 2026, selling an estimated $10.7M and leaving 538,310 shares worth $68M. The position accounts for 0.09% of the portfolio, ranked #193.

Corient Private Wealth first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $86.1M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Corient Private Wealth held 538,310 shares of Gilead Sciences worth $68M as of Q2 2026.
  • Corient Private Wealth sold 81,079 Gilead Sciences shares in Q2 2026, an estimated $10.7M.
  • Gilead Sciences made up 0.09% of Corient Private Wealth's portfolio in Q2 2026, its #193 holding.
  • Corient Private Wealth first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Gilead Sciences position peaked at $86.1M in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.